Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized presurgical exemestane schedule study in postmenopausal women with ER-positive breast cancer
2015-005063-16Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of exemestane in breast cancer (2 arms), sponsored by European Institute of Oncology. Started Dec 2020; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-005063-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005063-16.